Found 5 results
↓ CSVName | Type of Offering | Accepted Date |
---|---|---|
Vanquish Oncology, Inc.
See All Filings
|
D/A | 2014-04-10 |
Amount To Be Raised
$4,775,000
Associated Brokers / Dealers
N/A
CIK Number
0001572746
Filed Document
0001572746-14-000001
Exclusions or Exemptions
506b
Accepted Date
2014-04-10
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
ILLINOIS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Vanquish Oncology, Inc.
See All Filings
|
D | 2013-03-25 |
Amount To Be Raised
$4,775,000
Associated Brokers / Dealers
N/A
CIK Number
0001572746
Filed Document
0001572746-13-000001
Exclusions or Exemptions
N/A
Accepted Date
2013-03-25
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
ILLINOIS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Vanquish Oncology, Inc.
See All Filings
|
D | 2016-02-22 |
Amount To Be Raised
$7,350,000
Associated Brokers / Dealers
N/A
CIK Number
0001572746
Filed Document
0001572746-16-000001
Exclusions or Exemptions
506b
Accepted Date
2016-02-22
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
ILLINOIS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Vanquish Oncology, Inc.
See All Filings
|
D | 2020-07-01 16:52:17 |
Amount To Be Raised
$3,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001572746
Filed Document
0001572746-20-000001
Exclusions or Exemptions
506b
Accepted Date
2020-07-01 16:52:17
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
ILLINOIS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Vanquish Oncology, Inc.
See All Filings
|
D | 2019-06-19 12:01:23 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001572746
Filed Document
0001572746-19-000001
Exclusions or Exemptions
506b
Accepted Date
2019-06-19 12:01:23
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
ILLINOIS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|